Deerfield Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,555,871
| Closed | -$5.87M | – | 129 |
|
|
2024
Q4 | $5.87M | Hold |
3,555,871
| – | – | 0.11% | 68 |
|
|
2024
Q3 | $12.4M | Hold |
3,555,871
| – | – | 0.19% | 64 |
|
|
2024
Q2 | $11.7M | Buy |
3,555,871
+1,365,463
| +62% | +$4.48M | 0.19% | 64 |
|
|
2024
Q1 | $16.1M | Buy |
+2,190,408
| New | +$16.1M | 0.28% | 59 |
|
|
2021
Q4 | – | Sell |
-362,000
| Closed | -$21.5M | – | 133 |
|
|
2021
Q3 | $21.5M | Buy |
362,000
+58,000
| +19% | +$3.44M | 0.42% | 66 |
|
|
2021
Q2 | $26.4M | Hold |
304,000
| – | – | 0.47% | 71 |
|
|
2021
Q1 | $25.1M | Buy |
+304,000
| New | +$25.1M | 0.53% | 66 |
|
|
2020
Q4 | – | Sell |
-668,067
| Closed | -$26.7M | – | 28 |
|
|
2020
Q3 | $26.7M | Sell |
668,067
-245,708
| -27% | -$9.82M | 0.65% | 50 |
|
|
2020
Q2 | $31.4M | Sell |
913,775
-703,218
| -43% | -$24.1M | 0.91% | 36 |
|
|
2020
Q1 | $35.9M | Sell |
1,616,993
-385,612
| -19% | -$8.56M | 1.14% | 29 |
|
|
2019
Q4 | $39.2M | Buy |
2,002,605
+49,708
| +3% | +$973K | 1.25% | 28 |
|
|
2019
Q3 | $30.3M | Buy |
1,952,897
+250,000
| +15% | +$3.88M | 1.24% | 24 |
|
|
2019
Q2 | $34.6M | Hold |
1,702,897
| – | – | 1.24% | 23 |
|
|
2019
Q1 | $29.9M | Buy |
1,702,897
+48,032
| +3% | +$844K | 1.15% | 28 |
|
|
2018
Q4 | $21.2M | Buy |
1,654,865
+481,248
| +41% | +$6.17M | 0.85% | 41 |
|
|
2018
Q3 | $19.1M | Buy |
+1,173,617
| New | +$19.1M | 0.68% | 48 |
|